Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Calles A; Arregui M; Suárez-González J; García-Martos M; Márquez-Rodas I; Álvarez R; Martin M.

Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report.

JCO Precision Oncology. 2023; 7: Nº de citas: 3 [doi:10.1200/PO.23.00321]

Neven, P; Fasching, PA; Chia, S; Jerusalem, G; De Laurentiis, M; Im, SA; Petrakova, K; Bianchi, GV; Martin, M; Nusch, A; Sonke, GS; de la Cruz-merino, L; Beck, JT; Zarate, JP; Wang, Y; Chakravartty, A; Wang, C; Slamon, DJ.

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2-advanced breast cancer receiving first-line ribociclib plus fulvestrant

BREAST CANCER RESEARCH. 2023; 25(1): Nº de citas: 75 [doi:10.1186/s13058-023-01701-9]

Ramos-Ruperez, E; Escudero-Vilaplana, V; Ruiz-Briones, P; Collado-Borrell, R; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Garcia-Gonzalez, X; Ibanez-Garcia, S; Perez-Ramirez, S; Zatarain-Nicolas, E; Herranz, A; Sanjurjo, M.

Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

Frontiers in Oncology. 2023; 13: Nº de citas: 4 [doi:10.3389/fonc.2023.1220305]

Alnaqbi, KA; Bellanger, A; Brill, A; Castaneda-Hernandez, G; Estela, AC; Sanchez, OD; Garcia-Alfonso, P; Gyger, P; Heinrich, D; Hezard, G; Kakehasi, A; Koehn, C; Mariotte, O; Mennini, F; Perez-Tapia, S; Pistollato, M; Saada, R; Sasaki, T; Tambassis, G; Thill, M; Werutsky, G; Wilsdon, T; Simoens, S.

An international comparative analysis and roadmap to sustainable biosimilar markets

Frontiers in Pharmacology. 2023; 14: Nº de citas: 20 [doi:10.3389/fphar.2023.1188368]

Mendez-Vidal, MJ; Quintela, ML; Lainez-Milagro, N; Perez-Valderrama, B; Rodriguez, CS; Arija, JAA; Fernandez, IP; Diaz, EG; Sorrosal, JL; Gonzalez-del-Alba, A.

SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)

Clinical & Translational Oncology. 2023; 25(9): 2732-2748 Nº de citas: 7 [doi:10.1007/s12094-023-03276-5]

Gomez-Vecino, A; Corchado-Cobos, R; Blanco-Gomez, A; Garcia-Sancha, N; Castillo-Lluva, S; Martin-Garcia, A; Mendiburu-Elicabe, M; Prieto, C; Ruiz-Pinto, S; Pita, G; Velasco-Ruiz, A; Patino-Alonso, C; Galindo-Villardon, P; Vera-Pedrosa, ML; Jalife, J; Mao, JH; de Plasencia, GM; Castellanos-Martin, A; Saez-Freire, MD; Fraile-Martin, S; Rodrigues-Teixeira, T; Garcia-Macias, C; Galvis-Jimenez, JM; Garcia-Sanchez, A; Isidoro-Garcia, M; Fuentes, M; Garcia-Cenador, MB; Garcia-Criado, FJ; Garcia-Hernandez, JL; Hernandez-Garcia, MA; Cruz-Hernandez, JJ; Rodriguez-Sanchez, CA; Garcia-Sancho, AM; Perez-Lopez, E; Perez-Martinez, A; Gutierrez-Larraya, F; Carton, AJ; Garcia-Saenz, JA; Patino-Garcia, A; Martin, M; Alonso-Gordoa, T; Vulsteke, C; Croes, L; Hatse, S; Van Brussel, T; Lambrechts, D; Wildiers, H; Chang, H; Holgado-Madruga, M; Gonzalez-Neira, A; Sanchez, PL; Losada, JP.

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

Cells. 2023; 12(15): Nº de citas: 1 [doi:10.3390/cells12151956]

Munoz, AJ; Souto, JC; Lecumberri, R; Obispo, B; Sanchez, A; Aparicio, J; Aguayo, C; Gutierrez, D; Palomo, AG; Fanjul, V; del Rio-Bermudez, C; Vinuela-Beneitez, MC; Hernandez-Presa, MA.

Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning

THROMBOSIS RESEARCH. 2023; 228: 181-188 Nº de citas: 31 [doi:10.1016/j.thromres.2023.06.015]

Johnston, S; Emde, A; Barrios, C; Srock, S; Neven, P; Martin, M; Cameron, D; Janni, W; Gnant, M.

Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences

JNCI Cancer Spectrum. 2023; 7(4): Nº de citas: 17 [doi:10.1093/jncics/pkad045]

Dasari, A; Lonardi, S; Garcia-Carbonero, R; Elez, E; Yoshino, T; Sobrero, A; Yao, JM; Garcia-Alfonso, P; Kocsis, J; Gracian, AC; Sartore-Bianchi, A; Satoh, T; Randrian, V; Tomasek, J; Chong, GF; Paulson, AS; Masuishi, T; Jones, J; Csoszi, T; Cremolini, C; Ghiringhelli, F; Shergill, A; Hochster, HS; Krauss, J; Bassam, A; Ducreux, M; Elme, A; Faugeras, L; Kasper, S; Van Cutsem, E; Arnold, D; Nanda, S; Yang, Z; Schelman, WR; Kania, M; Tabernero, J; Eng, C.

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

LANCET. 2023; 402(10395): 41-53 Nº de citas: 265 [doi:10.1016/S0140-6736(23)00772-9]

Valcarcel, S; Gallego, J; Jimenez-Fonseca, P; Diez, M; de Castro, EM; Hernandez, R; Arrazubi, V; Custodio, A; Cano, JM; Montes, AF; Macias, I; Visa, L; Calvo, A; Tocino, RV; Lago, NM; Limon, ML; Granja, M; Gil, M; Pimentel, P; Macia-Rivas, L; Perez, CH; Mangas, M; Carnicero, AM; Cerda, P; Gonzalez, LG; Navalon, FG; Rambla, MDM; Richard, MM; Carmona-Bayonas, A.

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(7): 4077-4089 Nº de citas: 4 [doi:10.1007/s00432-022-04294-6]

Escudero-Vilaplana, V; Collado-Borrell, R; Martinez-Sagrera, PG; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Hoyo-Munoz, A; Gilarranz, YJ; Marzal-Alfaro, B; Herranz, A; Martin, M; Sanjurjo, M.

Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(7): 2855-2882 Nº de citas: 4 [doi:10.1007/s00432-022-04172-1]

Martin, M; Carrasco, E; Rodriguez-Lescure, A; Andres, R; Servitja, S; Anton, A; Ruiz-Borrego, M; Bermejo, B; Guerrero, A; Ramos, M; Santaballa, A; Munoz, M; Cruz, J; Lopez-Tarruella, S; Chacon, JI; Alvarez, I; Martinez, P; Miralles, JJ; Polonio, O; Jara, C; Aguiar-Bujanda, D.

Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El alamo IV registry

BREAST CANCER RESEARCH AND TREATMENT. 2023; 201(2): 151-159 Nº de citas: 10 [doi:10.1007/s10549-023-07002-1]

Canovas, MS; Garay, DF; Martinez, FG; Vazquez, EB; de Mena, ML; Adrian, SG; Pacheco-Barcia, V; Lavin, DC; de Castro, EM; de Soignie, AMMF; Martinez, E; Blanco, ABR; Escobar, IG; Coloma, CS; Boluda, NB; Garcia, MEG; Arroniz, MG; Martin, AJM.

Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group

Clinical & Translational Oncology. 2023; 26(1): 171-177 [doi:10.1007/s12094-023-03233-2]

Escobar, Y; Ramchandani, A; Salgado, M; Castillo-Trujillo, A; de Castro, EM; de Corcuera, ID; Vera, R; Lacalle, A; Torres, I; Segura, PP; Hierro, C; de Prado, DS; Cotes, A; Zafra, GM; Fabregat, RM; Virizuela, J; Villa, JC; Borrega, P; Jimenez-Fonseca, P.

What do patients and oncologists think about the evaluation and management of cancer-related anorexia-cachexia? The Quasar_SEOM study

Clinical & Translational Oncology. 2023; 25(12): 3479-3491 Nº de citas: 3 [doi:10.1007/s12094-023-03212-7]

Verso, M; Munoz, A; Agnelli, G.

Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents

SEMINARS IN ONCOLOGY. 2023; 50(3-5): 67-70 Nº de citas: 3 [doi:10.1053/j.seminoncol.2023.05.002]

Muñoz A; Ay C; Grilz E; López S; Font C; Pachón V; Castellón V; Martínez-Marín V; Salgado M; Martínez E; Calzas J; Ortega L; Rupérez A; Salas E; Pabinger I; Soria JM.

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.

JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(16): 2911-2925 Nº de citas: 46 [doi:10.1200/JCO.22.00255]

Vedovati, MC; Giustozzi, M; Munoz, A; Bertoletti, L; Cohen, AT; Klok, FA; Connors, JM; Bauersachs, R; Brenner, B; Campanini, M; Becattini, C; Agnelli, G.

Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism

European Journal of Internal Medicine. 2023; 112: 29-36 Nº de citas: 38 [doi:10.1016/j.ejim.2023.02.003]

Garcia-Pardo, M; Aparicio, I; Martinez, I; Arregui, M; Tirado, V; Galera, M; Alvarez, R; Calles, A.

Brief Report: Clinical Outcomes Using Plasma-Based Molecular Profiling to Guide Treatment Decisions in Patients With Advanced NSCLC and Limited Access to Broad Tissue Testing

Clinical Lung Cancer. 2023; 24(4): 366-370 Nº de citas: 3 [doi:10.1016/j.cllc.2023.02.003]